Hemodynamic Monitoring Systems Market worth 1,143.7 M USD by 2021

Thursday 18 August 2016, Amsterdam

The report, now available on ASDReports, "Hemodynamic Monitoring Systems Market by Product (Systems, & Disposables), Type (Invasive, Minimally invasive, & Non-invasive), End User (Hospitals, Cath labs, & Home and Ambulatory Care) - Global Forecasts to 2021", This report studies the global hemodynamic monitoring systems market during the forecast period of 2016 to 2021. This market is expected to reach USD 1,143.7 Million by 2021 from USD 925.2 Million in 2016, at a CAGR of 4.3%.

Factors such as technological advancements, growth in the number of people suffering from hypertension, growing diabetes population, and rapid growth in the aging population are driving the growth of the hemodynamic monitoring systems market. Moreover, growth in aging population and the number of people suffering from diseases in populous countries such as India and China are expected to offer significant growth opportunities for players in the hemodynamic monitoring Systems market. However, risks associated with invasive hemodynamic monitoring, such as sepsis, bleeding, hemorrhage, thrombosis, air embolism, and pulmonary capillary necrosis, are challenging the growth of the hemodynamic monitoring systems market.

In this report, the global hemodynamic monitoring systems market is segmented on the basis of product, type, end user, and region.

Based on products, the global hemodynamic monitoring systems market is segmented into systems and disposables. The disposables segment is estimated to account for the largest share of the global hemodynamic monitoring systems market in 2016, and is projected to grow at the highest CAGR in the forecast period.

Based on types, the global hemodynamic monitoring systems market is segmented into invasive, minimally invasive, and Noninvasive hemodynamic monitoring systems. The invasive monitoring systems segment is estimated to account for the largest share of the global hemodynamic monitoring systems market in 2016. The large share of this segment can be attributed to the increasing utilization of invasive hemodynamic monitoring systems in both intensive care units (ICUs) and operating theaters (OTs) for monitoring of patients with critical illnesses and hemodynamic instability.

Based on end users, the global hemodynamic monitoring systems market is broadly segmented into hospitals, cath labs and home and ambulatory sites. The hospitals segment is estimated to account for the largest share of the global market in 2016. Additionally, this segment is projected to grow at the highest CAGR during the forecast period.

On the basis of regions, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is estimated to account for the largest share of the global hemodynamic monitoring systems market, followed by Asia-Pacific, Europe, and the RoW. The Asia-Pacific market is projected to grow at the highest CAGR and serve as a revenue pocket for companies offering hemodynamic monitoring systems.

In 2015, the hemodynamic monitoring systems market was dominated by Edwards Lifesciences Corporation (U.S.), PULSION Medical Systems SE (Germany), and LiDCO Group plc. (U.K.). These companies accounted for a combined market share of 70% in 2015. The other players operating in the hemodynamic monitoring systems market are Cheetah Medical Inc. (Israel), Deltex Medical Group plc. (U.K.), Hemo Sapiens, Inc. (U.S.), ICU Medical, Inc. (U.S.), Osypka Medical GmbH (Germany), Schwarzer Cardiotek GmbH (Germany), and Tensys Medical, Inc. (U.S.).